The Experts below are selected from a list of 12672 Experts worldwide ranked by ideXlab platform
Claire V. Broome - One of the best experts on this subject based on the ideXlab platform.
-
Nonmenstrual Toxic Shock Syndrome
Annals of Internal Medicine, 2020Co-Authors: Arthur L. Reingold, Nancy T. Hargrett, Bruce B. Dan, Kathryn N. Shands, Barbara Y. Strickland, Claire V. BroomeAbstract:Abstract One hundred and thirty cases of Toxic Shock Syndrome not associated with menstruation have been reported to the Centers for Disease Control, including 57 with onset in 1981 (12% of reporte...
-
Toxic Shock Syndrome and Tampons
Epidemiologic reviews, 1991Co-Authors: Anne Schuchat, Claire V. BroomeAbstract:There has been a substantial reduction in the incidence of Toxic Shock Syndrome in the 10 years since the association between tampons and Toxic Shock Syndrome was first recognized. The decreased incidence is real, and not the result of decreased reporting to the passive surveillance system. The decreased incidence of menstrual Toxic Shock Syndrome can primarily be explained by changes in the absorbency and composition of tampons available to the consumer. The reduction in the occurrence of menstrual Toxic Shock Syndrome can be attributed to the withdrawal of Rely brand, which consisted of a unique composition, and subsequently to the lowering of absorbency of all brands of tampons. The conclusions of the early studies of Toxic Shock Syndrome pointed the way to prompt public health interventions and resulted in the prevention of substantial morbidity.
Arthur L. Reingold - One of the best experts on this subject based on the ideXlab platform.
-
Nonmenstrual Toxic Shock Syndrome
Annals of Internal Medicine, 2020Co-Authors: Arthur L. Reingold, Nancy T. Hargrett, Bruce B. Dan, Kathryn N. Shands, Barbara Y. Strickland, Claire V. BroomeAbstract:Abstract One hundred and thirty cases of Toxic Shock Syndrome not associated with menstruation have been reported to the Centers for Disease Control, including 57 with onset in 1981 (12% of reporte...
-
Toxic Shock Syndrome: An update
American Journal of Obstetrics and Gynecology, 1991Co-Authors: Arthur L. ReingoldAbstract:Since late 1979 to early 1980, when Toxic Shock Syndrome achieved notoriety, a substantial body of data has demonstrated that vaginal Staphylococcus aureus infections, particularly those occurring during menstruation, account for most cases of Toxic Shock Syndrome in women of reproductive age. Among those patients with onset during menstruation, tampon use has been identified as the most important risk factor. Although menstrually associated cases have been observed among users of all brands and styles of tampons, the use of selected "super absorbent" brands and styles has been associated with an increased risk of Toxic Shock Syndrome. Although the tampon characteristics responsible for the associated risk of Toxic Shock Syndrome remain poorly understood, both absorbency and chemical composition appear to be important variables in this relationship. In response to studies demonstrating this relationship and legal pressures, tampon manufacturers have removed chemical constituents previously used to enhance absorbency, such as polyester foam, carboxymethylcellulose, and polyacrylate rayon, and have markedly reduced tampon absorbency. Coinciding with these changes, the reported number of menstrually related cases of Toxic Shock Syndrome has dropped substantially, although they continue to account for 50% to 70% of all cases of Toxic Shock Syndrome in women of reproductive age.
F. G. Wolfort - One of the best experts on this subject based on the ideXlab platform.
-
Toxic Shock Syndrome as a complication of breast prostheses.
Plastic and reconstructive surgery, 1995Co-Authors: J. V. P. Poblete, J. A. Rodgers, F. G. WolfortAbstract:Infections involving breast prostheses are uncommon. The reported incidence is 2 to 3 percent for augmentation mammaplasty and slightly higher after reconstructive breast surgery.' Infection manifests itself as localized erythema, pain, swelling, and drainage from the operative site occurring between 6 days and 6 weeks postoperatively. 2 We report a case of post-operative infection after augmentation mammaplasty with severe systemic manifestations but minimal local signs of inflammation consistent with Toxic Shock Syndrome. Toxic Shock Syndrome is mainly associated with menstruation and the use of tampons, 3 but the incidence of nonmenstrual Toxic Shock Syndrome is increasing. It was first described in 1978 4 and has risen from 4 percent of Toxic Shock Syndrome cases in 1979 to 13 percent in 1981. 5 By 1986, Gaventa et al. 6 reported an incidence of 45 percent nonmenstrual Toxic Shock Syndrome using active surveillance for cases in a defined geographic area. Of increasing concern is the manifestation of Toxic Shock Syndrome in a variety of new clinical settings, notably postoperative wound infections, which now account for 16 percent of the reported cases of nonmenstrual Toxic Shock Syndrome. 7 In addition, nonmenstrual Toxic Shock Syndrome is associated with a higher mortality rate. 6 To our knowledge, four cases of Toxic Shock Syndrome associated with breast prostheses have been reported previously. 8-10 Our case illustrates the presentation of Toxic Shock Syndrome in the postoperative setting and serves to remind the clinician of this potentially devastating complication.
Nam Joong Kim - One of the best experts on this subject based on the ideXlab platform.
-
A Case of Group G Streptococcal Toxic Shock Syndrome
Infection and Chemotherapy, 2010Co-Authors: Shinwon Lee, Na Ra Yun, Kye-hyung Kim, Jae Hyun Jeon, Yu Min Kang, Gayeon Kim, Sang Won Park, Hong Bin Kim, Nam Joong KimAbstract:Toxic Shock Syndrome is an acute, multi-systemic, toxin-mediated illness caused by toxin-producing strains of Staphylococcus aureus and Streptococcus species. Streptococcal Toxic Shock Syndrome is usually caused by Streptococcus pyogenes but Group G streptococcal Toxic Shock Syndrome is rare.Herein,...
J. V. P. Poblete - One of the best experts on this subject based on the ideXlab platform.
-
Toxic Shock Syndrome as a complication of breast prostheses.
Plastic and reconstructive surgery, 1995Co-Authors: J. V. P. Poblete, J. A. Rodgers, F. G. WolfortAbstract:Infections involving breast prostheses are uncommon. The reported incidence is 2 to 3 percent for augmentation mammaplasty and slightly higher after reconstructive breast surgery.' Infection manifests itself as localized erythema, pain, swelling, and drainage from the operative site occurring between 6 days and 6 weeks postoperatively. 2 We report a case of post-operative infection after augmentation mammaplasty with severe systemic manifestations but minimal local signs of inflammation consistent with Toxic Shock Syndrome. Toxic Shock Syndrome is mainly associated with menstruation and the use of tampons, 3 but the incidence of nonmenstrual Toxic Shock Syndrome is increasing. It was first described in 1978 4 and has risen from 4 percent of Toxic Shock Syndrome cases in 1979 to 13 percent in 1981. 5 By 1986, Gaventa et al. 6 reported an incidence of 45 percent nonmenstrual Toxic Shock Syndrome using active surveillance for cases in a defined geographic area. Of increasing concern is the manifestation of Toxic Shock Syndrome in a variety of new clinical settings, notably postoperative wound infections, which now account for 16 percent of the reported cases of nonmenstrual Toxic Shock Syndrome. 7 In addition, nonmenstrual Toxic Shock Syndrome is associated with a higher mortality rate. 6 To our knowledge, four cases of Toxic Shock Syndrome associated with breast prostheses have been reported previously. 8-10 Our case illustrates the presentation of Toxic Shock Syndrome in the postoperative setting and serves to remind the clinician of this potentially devastating complication.
